Robert A Soslow Selected Research

Prostaglandin-E Synthases

1/2020	Withdrawal: Microsomal prostaglandin E synthase-1 is overexpressed in inflammatory bowel disease: Evidence for involvement of the transcription factor Egr-1.
3/2004	Microsomal prostaglandin E synthase-1 is overexpressed in inflammatory bowel disease. Evidence for involvement of the transcription factor Egr-1.
8/2003	Microsomal prostaglandin E synthase-1 is overexpressed in head and neck squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert A Soslow Research Topics

Disease

87	Neoplasms (Cancer) 01/2023 - 05/2002
45	Carcinoma (Carcinomatosis) 05/2023 - 10/2002
40	Endometrial Neoplasms (Endometrial Cancer) 10/2022 - 10/2002
20	Endometrioid Carcinoma 01/2023 - 10/2002
16	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 09/2003
13	Adenocarcinoma 05/2023 - 10/2002
8	Leiomyosarcoma 01/2019 - 09/2004
6	Mucinous Adenocarcinoma (Mucinous Carcinoma) 05/2023 - 01/2005
6	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 04/2013
6	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2020 - 11/2009
5	Carcinosarcoma 01/2022 - 05/2013
5	Carcinogenesis 04/2013 - 10/2002
5	Wilms Tumor (Wilm's Tumor) 01/2011 - 02/2008
4	Endometrial Stromal Sarcoma 01/2022 - 01/2005
4	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2006
4	Microsatellite Instability 01/2020 - 10/2012
4	Neoplasm Metastasis (Metastasis) 01/2017 - 08/2008
4	Uterine Neoplasms (Uterine Cancer) 01/2017 - 05/2006
3	Disease Progression 01/2021 - 09/2012
3	Renal Cell Carcinoma (Grawitz Tumor) 10/2017 - 08/2011
3	Leiomyoma (Uterine Fibroids) 10/2017 - 08/2011
2	Metaplasia 05/2023 - 01/2019
2	Hyperplasia 03/2022 - 03/2010
2	Adenosarcoma 01/2020 - 04/2013
2	Necrosis 01/2020 - 05/2013
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020 - 03/2004
2	Ovarian Epithelial Carcinoma 01/2018 - 10/2006
2	Leiomyomatosis 10/2017 - 07/2014
2	Small Cell Carcinoma 01/2016 - 09/2003
2	Colorectal Neoplasms (Colorectal Cancer) 12/2014 - 11/2009
2	Smooth Muscle Tumor 07/2014 - 04/2006
2	Carcinoma in Situ 12/2012 - 09/2008
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2006 - 05/2003
1	Histiocytosis 01/2023
1	Endometriosis 01/2023

Drug/Important Bio-Agent (IBA)

31	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2003
15	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 04/2006
13	Estrogen ReceptorsIBA 01/2022 - 01/2005
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2009
10	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 01/2005
9	MucinsIBA 05/2023 - 05/2008
8	Exonucleases (3' 5' Exonuclease)IBA 01/2020 - 04/2015
6	ParaffinIBA 01/2021 - 12/2004
6	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2018
6	Hematoxylin (Haematoxylon)IBA 01/2016 - 02/2004
6	Eosine Yellowish-(YS) (Eosin)IBA 01/2016 - 02/2004
5	Estrogens (Estrogen)FDA Link 09/2015 - 09/2004
5	AntibodiesIBA 05/2014 - 09/2003
4	Hormones (Hormone)IBA 01/2022 - 09/2015
4	DesminIBA 01/2021 - 01/2018
4	Cadherins (E-Cadherin)IBA 01/2019 - 10/2002
4	Sucrose (Saccharose)IBA 08/2018 - 03/2016
4	Coloring Agents (Dyes)IBA 01/2017 - 05/2009
4	Keratins (Keratin)IBA 03/2011 - 01/2005
3	MART-1 AntigenIBA 01/2022 - 09/2003
3	Cyclin D1IBA 01/2020 - 05/2014
3	Formaldehyde (Formol)FDA Link 01/2020 - 12/2004
3	Prostaglandin-E SynthasesIBA 01/2020 - 08/2003
3	Mucin-1 (CA 15-3 Antigen)IBA 01/2019 - 01/2005
3	VimentinIBA 01/2019 - 08/2006
3	Hepatocyte Nuclear FactorsIBA 03/2011 - 01/2009
3	AntigensIBA 10/2010 - 01/2005
3	Monoclonal AntibodiesIBA 01/2005 - 10/2002
2	Oral ContraceptivesIBA 05/2023 - 07/2013
2	temsirolimus FDA Link 10/2022 - 01/2018
2	Bevacizumab (Avastin)FDA Link 10/2022 - 01/2018
2	Trefoil Factor-2IBA 01/2022 - 01/2021
2	trans-sodium crocetinate (crocetin)IBA 01/2022 - 03/2015
2	taxaneIBA 01/2021 - 01/2018
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 10/2008
2	Phenobarbital (Luminal)FDA Link 01/2020 - 01/2018
2	Hepatocyte Nuclear Factor 1-betaIBA 01/2019 - 01/2018
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 01/2009
2	Androgen Receptors (Androgen Receptor)IBA 01/2018 - 09/2004
2	Carboplatin (JM8)FDA LinkGeneric 01/2018 - 01/2009
2	Fumarate Hydratase (Fumarase)IBA 10/2017 - 07/2014
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2017 - 01/2016
2	Tamoxifen FDA LinkGeneric 05/2013 - 05/2006
2	Carcinoembryonic AntigenIBA 05/2011 - 08/2006
2	Messenger RNA (mRNA)IBA 03/2009 - 08/2003
2	beta CateninIBA 10/2008 - 10/2002
2	Inhibins (Inhibin)IBA 07/2008 - 09/2003
1	Dasatinib (BMS 354825)FDA Link 01/2023
1	pembrolizumabIBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	Progestins (Progestagens)IBA 03/2022

Therapy/Procedure

27	Therapeutics 01/2023 - 05/2003
16	Drug Therapy (Chemotherapy) 10/2022 - 01/2009
13	Hysterectomy 01/2021 - 04/2007
9	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 05/2007
4	Neoadjuvant Therapy 01/2021 - 09/2009
4	Radiotherapy 01/2021 - 05/2003
3	Salpingo-oophorectomy 01/2021 - 11/2013
3	Adjuvant Chemotherapy 09/2013 - 03/2009
2	Laparotomy 01/2023 - 08/2008
2	Precision Medicine 02/2018 - 06/2014
2	Immunotherapy 01/2018 - 01/2005
2	Conservative Treatment 07/2016 - 12/2009
1	Duration of Therapy 01/2023
1	Minimally Invasive Surgical Procedures 01/2023